HUMAN DISEASE MODELED by WT + MO2-elp3
No data available

GENE EXPRESSION
Gene expression in WT + MO2-elp3

PHENOTYPE
Phenotype in WT + MO2-elp3

Phenotype	Conditions	Figures
adaxial cell ab1-eng labeling decreased amount, abnormal	standard conditions	Figure 4  from Rojas-Benítez et al., 2020
horizontal myoseptum morphology, abnormal	standard conditions	Figure 2  from Rojas-Benítez et al., 2020
motor neuron axon branched, abnormal	standard conditions	Fig. 4 from Simpson et al., 2009
motor neuron axon decreased length, abnormal	standard conditions	Fig. 4 from Simpson et al., 2009
muscle cell disorganized, abnormal	standard conditions	Figure 2  from Rojas-Benítez et al., 2020
notochord col2a1a expression decreased amount, abnormal	standard conditions	Figure 4  from Rojas-Benítez et al., 2020
post-vent region curved, ameliorated	chemical treatment by injection: purmorphamine	Figure 5  from Rojas-Benítez et al., 2020
post-vent region curved ventral, abnormal	standard conditions	Figure 1 ,  Figure 5  from Rojas-Benítez et al., 2020
somite decreased area, abnormal	standard conditions	Figure 2  from Rojas-Benítez et al., 2020
somite morphology, abnormal	standard conditions	Figure 2  from Rojas-Benítez et al., 2020
somite fast muscle cell disorganized, abnormal	standard conditions	Figure 3  from Rojas-Benítez et al., 2020
somite slow muscle cell morphology, abnormal	standard conditions	Figure 3  from Rojas-Benítez et al., 2020
somite slow muscle cell undulate, abnormal	standard conditions	Figure 3  from Rojas-Benítez et al., 2020
trunk curved, ameliorated	chemical treatment by injection: purmorphamine	Figure 5  from Rojas-Benítez et al., 2020
trunk curved ventral, abnormal	standard conditions	Figure 1 ,  Figure 5  from Rojas-Benítez et al., 2020
whole organism elp3 expression decreased amount, abnormal	control	Figure 1  from Rojas-Benítez et al., 2020